Complex Cost Issues in Treating Dermatophytoses in India-"It All Builds Up".
作者信息
Verma Shyam B
机构信息
Nirvan Skin Clinic, Makarpura Main Road, Vadodara, Gujarat, India.
出版信息
Indian Dermatol Online J. 2019 Jul-Aug;10(4):441-443. doi: 10.4103/idoj.IDOJ_98_19.
Abstract
摘要
相似文献
1
Complex Cost Issues in Treating Dermatophytoses in India-"It All Builds Up".印度皮肤癣菌病治疗中的复杂成本问题——“一切都在累积”
Indian Dermatol Online J. 2019 Jul-Aug;10(4):441-443. doi: 10.4103/idoj.IDOJ_98_19.
2
A Pilot Study for the Evaluation of PCR as a Diagnostic Tool in Patients with Suspected Dermatophytoses.一项评估聚合酶链反应（PCR）作为疑似皮肤癣菌病患者诊断工具的初步研究。
Indian Dermatol Online J. 2017 May-Jun;8(3):176-180. doi: 10.4103/idoj.IDOJ_138_16.
3
Dermatophytoses in India.
Bull Calcutta Sch Trop Med. 1969 Apr;17(2):54-9.
4
A twenty-year survey of dermatophytoses in Braga, Portugal.葡萄牙布拉加地区皮肤癣菌病的二十年调查
Int J Dermatol. 2006 Jul;45(7):822-7. doi: 10.1111/j.1365-4632.2006.02886.x.
5
Dermatophytoses in Kashmir, India.
Mykosen. 1987 Mar;30(3):135-8.
6
Prevalence and aetiology of dermatophytoses in Isfahan, Iran.伊朗伊斯法罕皮肤癣菌病的患病率及病因
Mycoses. 1997 Nov;40(7-8):321-4. doi: 10.1111/j.1439-0507.1997.tb00240.x.
7
Dermatophytoses in Poona, India. Observations on incidence, clinical features, environmental factors and causal agents studied during 1958 to 1963 at sassoon hospitals, Poona.印度浦那的皮肤癣菌病。1958年至1963年期间在浦那萨松医院对发病率、临床特征、环境因素和病原体的观察。
Mycopathol Mycol Appl. 1970 Aug 31;40(3):325-36. doi: 10.1007/BF02051785.
8
A clinico-epidemiological study of dermatophytoses in Northeast India.印度东北部皮肤癣菌病的临床流行病学研究。
Indian J Dermatol Venereol Leprol. 2007 Nov-Dec;73(6):427-8. doi: 10.4103/0378-6323.37068.
9
A study of dermatophytoses in Esfahan (Iran).伊朗伊斯法罕皮肤癣菌病的一项研究。
Mycopathologia. 1987 May;98(2):101-4. doi: 10.1007/BF00437295.
10
A clinical and mycological study of dermatophytoses.
Indian J Dermatol. 1983 Oct;28(4):163-4.
引用本文的文献
1
Comparative evaluation of the efficacy of itraconazole with terbinafine cream versus itraconazole with sertaconazole cream in dermatophytosis: A within person pilot study.伊曲康唑联合特比萘芬乳膏与伊曲康唑联合舍他康唑乳膏治疗皮肤癣菌病疗效的比较评估：一项自身对照的初步研究。
Med J Armed Forces India. 2023 Sep-Oct;79(5):526-530. doi: 10.1016/j.mjafi.2021.07.001. Epub 2021 Sep 23.
2
-An Emerging Pathogen Causing Recalcitrant Dermatophytoses in India and Worldwide-A Multidimensional Perspective.- 一种在印度及全球引发顽固性皮肤癣菌病的新兴病原体——多维视角
J Fungi (Basel). 2022 Jul 21;8(7):757. doi: 10.3390/jof8070757.
3
Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) Task Force against Recalcitrant Tinea (ITART) Consensus on the Management of Glabrous Tinea (INTACT).印度皮肤科、性病科和麻风病科医生协会（IADVL）顽固性癣病特别工作组（ITART）关于光滑皮肤癣菌病管理的共识（INTACT）
Indian Dermatol Online J. 2020 Jul 13;11(4):502-519. doi: 10.4103/idoj.IDOJ_233_20. eCollection 2020 Jul-Aug.
4
Psychosocial and Financial Impact of Disease among Patients of Dermatophytosis, a Questionnaire-Based Observational Study.基于问卷调查的观察性研究：皮肤癣菌病患者疾病的心理社会和经济影响
Indian Dermatol Online J. 2020 May 10;11(3):373-377. doi: 10.4103/idoj.IDOJ_331_19. eCollection 2020 May-Jun.
本文引用的文献
1
Emergence of recalcitrant dermatophytosis in India.印度顽固性皮肤癣菌病的出现。
Lancet Infect Dis. 2018 Jul;18(7):718-719. doi: 10.1016/S1473-3099(18)30338-4.
2
End of the road for terbinafine? Results of a pragmatic prospective cohort study of 500 patients.特比萘芬之路走到尽头了吗？一项针对500名患者的实用前瞻性队列研究结果
Indian J Dermatol Venereol Leprol. 2018 Sep-Oct;84(5):554-557. doi: 10.4103/ijdvl.IJDVL_526_17.
3
Emergence of recalcitrant dermatophytosis in India.印度顽固性皮肤癣菌病的出现。
Lancet Infect Dis. 2018 Mar;18(3):250-251. doi: 10.1016/S1473-3099(18)30079-3.
4
Rational use of drugs in dermatology: A paradigm lost?皮肤病学中药物的合理使用：一种失落的范式？
Indian J Dermatol Venereol Leprol. 2018 Jan-Feb;84(1):1-5. doi: 10.4103/ijdvl.IJDVL_886_17.
5
Dermatophytosis: Fighting the Challenge: Conference Proceedings and Learning Points. September 2-3, 2017, PGIMER, Chandigarh, India.皮肤癣菌病：应对挑战：会议论文集及学习要点。2017年9月2日至3日，印度昌迪加尔医学教育与研究研究生院
Indian Dermatol Online J. 2017 Nov-Dec;8(6):527-533. doi: 10.4103/idoj.IDOJ_283_17.
6
The Great Indian Epidemic of Superficial Dermatophytosis: An Appraisal.印度浅表皮肤癣菌病大流行：评估
Indian J Dermatol. 2017 May-Jun;62(3):227-236. doi: 10.4103/ijd.IJD_206_17.
7
The menace of chronic and recurrent dermatophytosis in India: Is the problem deeper than we perceive?印度慢性复发性皮肤癣菌病的威胁：问题是否比我们所认为的更为严重？
Indian Dermatol Online J. 2016 Mar-Apr;7(2):73-6. doi: 10.4103/2229-5178.178100.
8
Medication misuse in India: a major public health issue in India.印度的药物滥用：印度一个主要的公共卫生问题。
J Public Health (Oxf). 2016 Jun;38(2):e150-7. doi: 10.1093/pubmed/fdv072. Epub 2015 Jun 8.
9
Healthcare agenda for the Indian government.印度政府的医疗保健议程。
Indian J Med Res. 2015 Feb;141(2):151-3. doi: 10.4103/0971-5916.155541.
Zotero 插件